ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,796 | +236.4% | 228,642 | +427.5% | 0.00% | – |
| Q2 2023 | $215,431 | -90.0% | 43,346 | -90.0% | 0.00% | -100.0% |
| Q1 2023 | $2,149,000 | +1480.1% | 435,020 | +3354.5% | 0.01% | – |
| Q3 2022 | $136,000 | -99.0% | 12,593 | -98.7% | 0.00% | -100.0% |
| Q4 2021 | $14,153,000 | +18.9% | 948,624 | +107.8% | 0.03% | -51.9% |
| Q2 2021 | $11,908,000 | +364.1% | 456,591 | +245.9% | 0.05% | +107.7% |
| Q1 2020 | $2,566,000 | -35.5% | 132,006 | -13.8% | 0.03% | -3.7% |
| Q4 2019 | $3,977,000 | +657.5% | 153,105 | +684.2% | 0.03% | +575.0% |
| Q2 2019 | $525,000 | -85.3% | 19,524 | -84.2% | 0.00% | -76.5% |
| Q1 2019 | $3,564,000 | – | 123,284 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |